Turbocef 1.5 gm/vial IV Injection 1.5 gm vial

Name: Turbocef 1.5gm IV injection price in Bangladesh
Brand: Beximco Pharmaceuticals Ltd
Price: 200.0 BDT
Availability: InStock

Brand: Beximco Pharmaceuticals Ltd

Category: Cefuroxime Axetil

TK. 200

Highlights:

Country of Origin: Bangladesh
Quantity Per Pack: 1 Pcs
Medicine Type : Injection

রকমারি মেগা সেল-এ ইন্সট্যান্ট ১০০৳ ক্যাশব্যাক বিকাশ ৯৯৯৳ পেমেন্টে | BOGO | Exclusive Gift | Quick Deal 🔥

Add to Cart

Specification
Title:	Turbocef 1.5 gm/vial IV Injection 1.5 gm vial
Brand:	Beximco Pharmaceuticals Ltd
Country of Origin	Bangladesh
Quantity Per Pack	1 Pcs
Medicine Type	Injection
Brand	Beximco
Origin	Bangladesh
Form	Vial
Benefit	Relief
Pack Size	1 Vial
Use	Infection
Product name	Turbocef 1.5gm
Medicine Type	IV Injection
Specification	Details
Strength	1.5gm

Summary

Turbocef 1.5gm IV injection

The Turbocef 1.5gm IV injection is a trusted Beximco 1.5gm vial medicine. The 1.5 g Turbocef injection treats infection quickly and effectively. The Turbocef IV injection vial is easy to use under the guidance of a healthcare professional. The infusion works fast and is very reliable. The medicine is available and safe in Bangladesh.

Features and Benefits

✅ Quick Infection Relief: The Turbocef 1.5gm IV injection reduces infection symptoms fast and restores health safely.

✅ Fast Symptom Control: Beximco 1.5gm vial calms infection effects quickly and promotes recovery effectively.

✅ Easy Administration: 1.5 g of Turbocef injection is simple to use under medical supervision, safely daily.

✅ Trusted Brand Quality: The Turbocef IV injection vial is produced under strict safety standards in Bangladesh.

✅ Cost-Effective Medicine: Turbocef 1.5gm IV injection provides reliable infection treatment without extra expense.

Best Price Offer: The Turbocef 1.5gm IV injection is available at the best price in Bangladesh on Rokomari.com. Grab it now from us.

Report incorrect information

Brand Information

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around the world. Beximco Pharma is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories and the Company has created strong differentiation by offering a range of high-tech, specialized products which are difficult to imitate.